The latest news for pharma industry insiders.
In the final part of his video interview with Editor Nicholas Saraceno, Tom Dorsett, CEO, RazorMetrics, describes how the software company’s solution can help deliver better patient outcomes and substantial savings for healthcare plans, employers, and members alike.
Markary, a surgeon at Johns Hopkins, gave safe, vague and polished answers to senators' questions on mifepristone and the cancellation of an FDA vaccine committee meeting.
Andrew Barto and Richard Sutton developed reinforcement learning, a technique vital to chatbots like ChatGPT.
Bristol Myers Squibb has announced that the European Commission (EC) has approved Opdivo® (nivolumab) plus Yervoy® (ipilimumab) for the first-line treatment of adult patients with unresectable or advanced hepatocellular carcinoma.
The opioid and fentanyl crisis underscores an urgent need for safer, non-addictive pain treatments.
South Rampart Pharma, Inc. CEO Hernan Bazan, MD, DFSVS, FACS recently spoke with
Highlights include:
✅ Progress advancing our lead candidate, SRP-001, into Phase 2 clinical trials
✅ Leveraging support from NIH’s HEAL Initiative
✅ Designing scientifically rigorous and clinically meaningful pain trial endpoints
Read the full interview:
#PainManagement #PharmaInnovation #OpioidCrisis #Healthcare
Have news you want us to share in Pharma Pulse? Reach out to Editor
